Prudential Financial Inc. Cuts Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Prudential Financial Inc. reduced its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 12.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 161,493 shares of the company’s stock after selling 22,551 shares during the period. Prudential Financial Inc. owned approximately 0.33% of Prestige Consumer Healthcare worth $12,611,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Kestra Investment Management LLC purchased a new stake in Prestige Consumer Healthcare during the fourth quarter worth about $27,000. GAMMA Investing LLC grew its holdings in shares of Prestige Consumer Healthcare by 18.9% in the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock worth $108,000 after acquiring an additional 220 shares during the period. KBC Group NV grew its holdings in shares of Prestige Consumer Healthcare by 28.3% in the 4th quarter. KBC Group NV now owns 2,048 shares of the company’s stock worth $160,000 after acquiring an additional 452 shares during the period. Blue Trust Inc. increased its stake in Prestige Consumer Healthcare by 24.8% in the 4th quarter. Blue Trust Inc. now owns 2,190 shares of the company’s stock valued at $158,000 after purchasing an additional 435 shares in the last quarter. Finally, Longboard Asset Management LP acquired a new position in Prestige Consumer Healthcare during the fourth quarter worth $201,000. 99.95% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, SVP Mary Beth Fritz sold 1,678 shares of the stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the transaction, the senior vice president now directly owns 17,157 shares in the company, valued at $1,544,130. This represents a 8.91 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.60% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

PBH has been the subject of a number of research analyst reports. Raymond James upgraded Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Tuesday, March 18th. Oppenheimer upped their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a report on Thursday, February 13th. Royal Bank of Canada raised their price objective on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a “sector perform” rating in a research note on Friday, March 21st. Finally, Sidoti lowered Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 target price on the stock. in a research note on Monday, December 9th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, Prestige Consumer Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $93.33.

Prestige Consumer Healthcare Stock Performance

NYSE:PBH opened at $86.07 on Friday. Prestige Consumer Healthcare Inc. has a 1-year low of $62.35 and a 1-year high of $90.04. The firm has a 50 day simple moving average of $83.17 and a 200-day simple moving average of $78.89. The firm has a market cap of $4.26 billion, a PE ratio of 20.16, a P/E/G ratio of 2.69 and a beta of 0.46. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. On average, equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.